| Literature DB >> 12050147 |
Beth L Roman1, Van N Pham, Nathan D Lawson, Magdalena Kulik, Sarah Childs, Arne C Lekven, Deborah M Garrity, Randall T Moon, Mark C Fishman, Robert J Lechleider, Brant M Weinstein.
Abstract
The zebrafish mutant violet beauregarde (vbg) can be identified at two days post-fertilization by an abnormal circulation pattern in which most blood cells flow through a limited number of dilated cranial vessels and fail to perfuse the trunk and tail. This phenotype cannot be explained by caudal vessel abnormalities or by a defect in cranial vessel patterning, but instead stems from an increase in endothelial cell number in specific cranial vessels. We show that vbg encodes activin receptor-like kinase 1 (Acvrl1; also known as Alk1), a TGFbeta type I receptor that is expressed predominantly in the endothelium of the vessels that become dilated in vbg mutants. Thus, vbg provides a model for the human autosomal dominant disorder, hereditary hemorrhagic telangiectasia type 2, in which disruption of ACVRL1 causes vessel malformations that may result in hemorrhage or stroke. Movies available on-lineEntities:
Mesh:
Substances:
Year: 2002 PMID: 12050147 DOI: 10.1242/dev.129.12.3009
Source DB: PubMed Journal: Development ISSN: 0950-1991 Impact factor: 6.868